|
Jan 9
|
OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser’s Option to Purchase Additional Notes
|
|
Dec 7
|
Here's Why You Should Retain OPKO Health (OPK) Stock for Now
|
|
Dec 6
|
Why Is OPKO Health (OPK) Up 18.7% Since Last Earnings Report?
|
|
Nov 15
|
Phillip Frost Spends US$1.3m On OPKO Health Stock
|
|
Nov 7
|
Q3 2023 OPKO Health Inc Earnings Call
|
|
Nov 7
|
OPKO Health (OPK) Q3 Earnings Lag Estimates, Revenues Top
|
|
Nov 7
|
OPKO Health, Inc. (NASDAQ:OPK) Q3 2023 Earnings Call Transcript
|
|
Nov 7
|
BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™
|
|
Nov 7
|
Opko Health (OPK) Q3 2023 Earnings Call Transcript
|
|
Nov 7
|
OPKO Health (OPK) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
|
|
Nov 6
|
OPKO Health Inc (OPK) Reports Third Quarter 2023 Financial Results
|
|
Nov 6
|
OPKO Health Reports Third Quarter 2023 Business Highlights and Financial Results
|
|
Nov 2
|
New Clinical Data on OPKO Health’s RAYALDEE® (ER Calcifediol) Presented at Kidney Week 2023
|
|
Oct 25
|
OPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023
|
|
Sep 12
|
Entera Bio Announces Collaboration with OPKO Biologics to Develop Oral Peptide Tablet Formulations for Obesity and Intestinal Malabsorption Syndromes
|
|
Aug 7
|
OPKO Health (OPK) Q2 Earnings and Revenues Top Estimates
|
|
Aug 4
|
Opko Health (OPK) Q2 2023 Earnings Call Transcript
|
|
Aug 3
|
OPKO Health (OPK) Reports Q2 Loss, Tops Revenue Estimates
|
|
Aug 3
|
OPKO Health Reports Second Quarter 2023 Business Highlights and Financial Results
|
|
Jul 25
|
OPKO Health to Report Second Quarter 2023 Financial Results on August 3, 2023
|